Vivek Subbiah, Professor at Stanford University, shared on LinkedIn:
“Such an honor to be invited to New York for United Nations General Assembly UNGA High‑Level Week 2026 stepping beyond the silos of clinic and clinical trials to engage directly with policymakers on what it will take to move precision oncology forward.
Thanks to International Alliance for Personalised Medicine to convene the dialogue. The discussions underscored how policies in precision medicine shapes innovation, investment, diagnostics, manufacturing and ultimately patient access across borders.
The meeting convened ministers, health‑system leaders, regulators, industry, payers, investors, clinicians and patients to connect evidence, regulation, HTA, reimbursement, procurement, financing, workforce and infrastructure into one coherent pathway from innovation to care.
We can’t control the weather or the currents. But we can build a stronger vessel, steer with intention, and keep the patient at the center of every decision.”
You can also read:
Soham Banerjee at COGC 2026: The Essential Role of Molecular Tumor Boards in Precision Oncology
